ArticleFrontiers in oncology2013

Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study.

Chunqiao Q Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.